China Resources Capital Management is a private equity fund management platform specializing in healthcare, urban construction, consumer products, clean energy, and technology innovation. With a focus on strategic emerging industries, the company manages 24 funds and 3 investment platforms, totaling RMB 110 billion in assets under management and 170 portfolio companies. Founded as a subsidiary of China Resources (Holdings) Co., Ltd, it aligns with national policies and CR Group's core businesses.
Leadership
Name | Title | ||
---|---|---|---|
Qiu Xiaochun | Fund Director, CR-BECE New Energy Fund and Big Data Fund |
in/xiaochun-qiu-a3177a27
|
|
Managing Director, CR & CNIC INVESTMENT LIMITED |
|
||
CEO, CR Pharmaceutical Fund | |||
Managing Director, Asia Food Fund | |||
Managing Director, CR Everbright Health Industry FOF |
Recent Transactions involving China Resources Capital Management
Deal | Target | Platform | Buyer | Industry |
---|---|---|---|---|
Investcorp completes its fourth food investment as part of its growth strategy in Asia by investing in Mo Xiaoxian, a leading instant food brand in China |
Mo Xiaoxian |
China Resources Capital ManagementInvestcorpFung Group |
||
|
|
|
The Lower and Middle Market M&A Platform
See how PrivSource can help you close more deals.
Learn more →